Further preclinical PET imaging studies utilizing a human/mouse MMR cross-reactive 18F-labeled nanobody in a mouse model of lung cancer validated MMR+-macrophage imaging, suggesting it can serve as a suitable imaging tool for ultimate clinical translation 19. Here, MRC1 is linked to lung cancer.